Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BDX | NYSE | USD | Real-time | |
BDX | BIVA | MXN | Delayed | |
1BDX | Milan | EUR | Real-time | |
BDX | Vienna | EUR | Real-time |
For the nine months ended 30 June 2016, Becton Dickinson and Co revenues increased 28% to $9.25B. Net income increased 87% to $958M. Revenues reflect Life Sciences segment increase of 5% to $963M, Medical Systems segment increase of 2% to $2.24B, United States segment increase of 2% to $1.74B, International segment increase of 3% to $1.46B.
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Revenue | 2051 | 2051 | 2202 | 2157 |
Gross Profit | 1046 | 1045 | 1102 | 1111 |
Operating Income | 293 | 349 | 401 | 445 |
Net Income | 216 | 235 | 301 | 326 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Assets | 28293 | 18503 | 12447 | 12374 |
Total Liabilities | 21134 | 13435 | 7394 | 6996 |
Total Equity | 7159 | 5068 | 5053 | 5378 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | 514 | 286 | 1746 | 1207 |
Cash From Investing Activities | -7829 | 368 | -948 | -730 |
Cash From Financing Activities | 7392 | 6033 | -807 | -701 |
Net Change in Cash | 51 | 6679 | -29 | -229 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review